BackCo-Diagnostics Overview

Co-Diagnostics Operating Income

Co-Diagnostics's operating income is $-48M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

-$6.27M
↑ 10.61% YoY

As of Sep 30, 2026

Annual Operating Income (TTM)

-$48.22M
↓ 35.71% YoY

Trailing 12 months ending Sep 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Co-Diagnostics (CODX) FAQ

As of the most recent data (September 2026), CODX shows a operating income of $-48M. That compares with $-36M in the prior-year period — down 35.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CODX's operating income is now $-48M (was $-36M) — a 35.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Co-Diagnostics is outperforming or lagging.

Tracking CODX's operating income over time shows whether Co-Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $-48M That compares with $-36M in the prior-year period — down 35.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Co-Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-48M) with ownership activity and broader fundamentals.

Co-Diagnostics's operating income is $-48M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.